| 9ri3 |
SARS-CoV-2 with a bound inhibitor |
1 |
1 |
X-RAY DIFFRACTION |
| 9ri4 |
SARS-CoV-2 with a bound inhibitor |
1 |
1 |
X-RAY DIFFRACTION |
| 9ri5 |
SARS-CoV-2 with a bound inhibitor |
1 |
1 |
X-RAY DIFFRACTION |
| 9ri8 |
SARS-CoV-2 with a bound inhibitor |
1 |
1 |
X-RAY DIFFRACTION |
| 9ri9 |
Cryo-EM structure of the tomato NRC3 hexameric resistosome |
1 |
1 |
ELECTRON MICROSCOPY |
| 9ria |
Cryo-EM structure of tomato NRC3-AVRcap1b complex |
1 |
1 |
ELECTRON MICROSCOPY |
| 9rib |
Crystal structure of C278S mutant of mouse CDC14A |
2 |
2 |
X-RAY DIFFRACTION |
| 9rid |
SARS-CoV-2 with a bound inhibitor |
1 |
1 |
X-RAY DIFFRACTION |
| 9rif |
The histone fold domain heterodimer of oocyst rupture proteins 1 and 2 from Plasmodium berghei |
6 |
6 |
X-RAY DIFFRACTION |
| 9rig |
EV-A71 (genotype B2) in complex with 16-2-9D Fab |
1 |
1 |
ELECTRON MICROSCOPY |
| 9rih |
EV-A71 (genotype B2) in complex with 16-2-12D Fab |
1 |
1 |
ELECTRON MICROSCOPY |
| 9rii |
EV-A71 (genotype B2) in complex with 34-1-6D Fab |
1 |
1 |
ELECTRON MICROSCOPY |
| 9rij |
EV-A71 (genotype B5) in complex with 16-2-8C Fab |
1 |
1 |
ELECTRON MICROSCOPY |
| 9rik |
EV-A71 (genotype B5) in complex with 16-2-2D Fab |
1 |
1 |
ELECTRON MICROSCOPY |
| 9ril |
EV-A71 (genotype B5) in complex with 16-3-3C Fab |
1 |
1 |
ELECTRON MICROSCOPY |
| 9rim |
EV-A71 (genotype B5) in complex with 16-3-4D Fab |
1 |
1 |
ELECTRON MICROSCOPY |
| 9rin |
EV-A71 (genotype B5) in complex with 17-1-12A Fab |
1 |
1 |
ELECTRON MICROSCOPY |
| 9rio |
EV-A71 (genotype B5) in complex with 17-2-2B Fab |
1 |
1 |
ELECTRON MICROSCOPY |
| 9rip |
EV-A71 (genotype B5) in complex with 17-2-12A Fab |
1 |
1 |
ELECTRON MICROSCOPY |
| 9riq |
EV-A71 (genotype C4) in complex with 16-2-11B Fab |
1 |
1 |
ELECTRON MICROSCOPY |
| 9rir |
EV-A71 (genotype C4) in complex with 16-3-10B Fab |
1 |
1 |
ELECTRON MICROSCOPY |
| 9ris |
Crystal structure of human IDO1 in complex with iDeg-1 |
1 |
1 |
X-RAY DIFFRACTION |
| 9rit |
Co-crystal of broadly neutralizing biparatopic VHH in complex with cardiotoxin (P01468) Naja pallida |
2 |
2 |
X-RAY DIFFRACTION |
| 9riu |
Co-crystal of broadly neutralizing VHH in complex with short neurotoxin 1 (P01426) Naja pallida |
2 |
2 |
X-RAY DIFFRACTION |
| 9riv |
Population B fibril generated from the Heterotypic interaction of Abeta40 and Medin. |
1 |
1 |
ELECTRON MICROSCOPY |
| 9riw |
Population A fibril generated from the Heterotypic interaction of Abeta40 and Medin. |
1 |
1 |
ELECTRON MICROSCOPY |
| 9rix |
SARS-CoV-2 with a bound inhibitor |
1 |
1 |
X-RAY DIFFRACTION |
| 9riy |
SARS-CoV-2 with a bound inhibitor |
1 |
1 |
X-RAY DIFFRACTION |
| 9riz |
SARS-CoV-2 with a bound inhibitor |
1 |
1 |
X-RAY DIFFRACTION |
| 9rj0 |
SARS-CoV-2 with a bound inhibitor |
1 |
1 |
X-RAY DIFFRACTION |
| 9rj1 |
S-methylcysteine synthase (BSAS4) from common bean in complex with PLP, BEZ, and GOL |
1 |
1 |
X-RAY DIFFRACTION |
| 9rj3 |
SARS-CoV-2 with a bound inhibitor |
1 |
1 |
X-RAY DIFFRACTION |
| 9rj5 |
SARS-CoV-2 with a bound inhibitor |
1 |
1 |
X-RAY DIFFRACTION |
| 9rj7 |
SARS-CoV-2 with a bound inhibitor |
1 |
1 |
X-RAY DIFFRACTION |
| 9rj8 |
SARS-CoV-2 with a bound inhibitor |
1 |
1 |
X-RAY DIFFRACTION |
| 9rj9 |
[FeFe]-hydrogenase CpI from Clostridium pasteurianum, variant N160L |
2 |
2 |
X-RAY DIFFRACTION |
| 9rja |
Manikomycin bound to the Escherichia coli 70S ribosome |
1 |
1 |
ELECTRON MICROSCOPY |
| 9rjb |
Human Signal Peptidase in complex with artificial Signal Peptide L11 |
1 |
1 |
ELECTRON MICROSCOPY |
| 9rjc |
Apo Structure of the Human Signal Peptidase |
1 |
1 |
ELECTRON MICROSCOPY |
| 9rjf |
SARS-CoV-2 with a bound inhibitor |
1 |
1 |
X-RAY DIFFRACTION |
| 9rjg |
Structure of Mycobacterium tuberculosis InhA in complex with pyridomycin (compound 1) |
2 |
2 |
X-RAY DIFFRACTION |
| 9rjh |
Structure of Mycobacterium tuberculosis InhA in complex with pyridomycin-derivative KV26a (compound 4) |
2 |
2 |
X-RAY DIFFRACTION |
| 9rji |
Structure of Mycobacterium tuberculosis InhA in complex with pyridomycin-derivative KV29a (compound 5) |
2 |
2 |
X-RAY DIFFRACTION |
| 9rjj |
Structure of Mycobacterium tuberculosis InhA in complex with pyridomycin derivative KV37a (compound 9) |
2 |
2 |
X-RAY DIFFRACTION |
| 9rjk |
Structure of Mycobacterium tuberculosis InhA in complex with pyridomycin derivative KV41a (compound 11) |
1 |
1 |
X-RAY DIFFRACTION |
| 9rjl |
Structure of Mycobacterium tuberculosis InhA in complex with pyridomycin derivative KV35a (compound 12) |
2 |
2 |
X-RAY DIFFRACTION |
| 9rjm |
Structure of Mycobacterium tuberculosis InhA in complex with pyridomycin derivative EP196 (compound 13) |
2 |
2 |
X-RAY DIFFRACTION |
| 9rjn |
Structure of Mycobacterium tuberculosis InhA in complex with pyridomycin derivative KV32a (compound 14) |
1 |
1 |
X-RAY DIFFRACTION |
| 9rjo |
[FeFe]-hydrogenase CpI from Clostridium pasteurianum, variant N160L-Q195L |
2 |
2 |
X-RAY DIFFRACTION |
| 9rjp |
Structure of Mycobacterium tuberculosis InhA in complex with pyridomycin derivative KV25a (compound 15) |
1 |
1 |
X-RAY DIFFRACTION |